Objective: Methicillin-resistant Staphylococcus aureus (MRSA) widely distributed in hospitals around the world. There is strong relationship between disease development and S. aureus nasal carriage. The aim of this study was to evaluate the prevalence and epidemiology of nasal colonization with S. aureus and MRSA in the community of Duhok city, Iraq.
INTRODUCTION
Staphylococcus aureus is considered to be one of the most important resistant pathogen and it was one of the earliest microorganisms in which penicillin resistance was detected. 1 Pencillin-resistant S. aureus became a major threat in hospitals in the 1950s leading to the use of methicillin. 2 However, methicillin resistant strains appeared amongst S. aureus strains isolated from hospitals in 1961. 3 Methicillin-resistant S. aureus (MRSA) has become one of the most important hospitals and community acquired causative agents of human skin infections and invasive diseases, such as pneumonia, endocarditis, deep abscess formation, osteomyelitis, and septic arthritis. 2, 4 Colonisation or infection of MRSA was generally considered to be hospital associated (HA-MRSA). 4 However, strains of MRSA have emerged in the community and often known as community-associated MRSA (CA-MRSA). 5 CA-MRSA differs from HA-MRSA as CA-MRSA is likely to be more susceptible to other antibiotics such as trimethoprim-sulfamethoxazole (TMP/SMX). 6 Additionally, CA-MRSA carries staphylococcal cassette chromosome methicillin resistant locus (SCCmec) type IV or V. 7 It is documented that a major predisposing factor for succeeding infection and transmission of MRSA is the presence of this pathogen in the nose. 1, 8 Some publications suggested that the percentage of nasal carriers MRSA adults is about 7%. 9 Further studies showed that 10% to 35% of populations harbour MRSA in the nose transiently or persistently and up to 30% of healthy people have S. aureus in their nose or other body areas. 10 In a study conducted in the United States, the nasal carriage rate of CA-MRSA in children increased from 0.6% in 2001 to 1.3% in 2004. 11 Several studies have been conducted with medical students, 12, 13 but few studies have examined the characteristics of CA-MRSA in a general student population.
14, 15 The purposes of this report were to evaluate the prevalence of nasal carriage of S. aureus and MRSA, to study the prevalence of PVL and to examine the vancomycin sensitivity pattern amongst student population in Duhok city, Iraq.
METHODS

Sample collection
To ensure adequate sample size, 489 secondary school students in Duhok city were included in the study, aged 16 through 18 years. In order to fulfil the case definition of CA-MRSA infection according to the Center for Disease Control and Prevention (CDC), those students with one of the following HA-MRSA risk factors were excluded: (1) diagnosis of MRSA infection within two days of hospitalization, (2) Previous admission to hospital, undergoing surgical procedures, renal dialysis and long-term stay in a care unit within a year of the nasal swab taking, (3) Using of an catheter or intravenous line at the time of swab taking (4) Former detection of MRSA from the subject. 16 Also the included students should not have received antibiotics recently, should not have lived with a person who has chronic disease that need frequent hospital visits and should not have received care for wound infection. The study was conducted with the approval of ethics committee in the University of Duhok, School of Medicine.
Cultural and biochemical identification of MRSA and antimicrobial susceptibility testing
Nasal swabs were taken from both anterior nares of the students. To avoid or minimize the mild irritation that may happen by dry swabs, swabs were moistened with sterile distilled water. 10 The swab was inserted about 2 cm, with rotating 3 seconds, into the naris. The same swab was used for other naris. Then, the swabs were directly cultured in Mannitol Salt Agar (Oxoid), and incubated at 35ºC for 48 hours. The strains were considered S. aureus relying on mannitol salt agar fermentation, Gram stain, morphology, catalase test and coagulase test. Antimicrobial susceptibility testing to antimicrobial agents including oxacillin and vancomycin was performed by the Kirby-Bauer disk diffusion and agar dilution assay methods, vancomycin sensitivity was tested on Muller-Hinton agar (Oxoid Limited, Hampshire, England), according to the Clinical Laboratory Standards Institute (CLSI) recommendations. Further investigations were performed for MRSA isolates, including polymerase chain reaction (PCR) assays for the mecA gene and the genes that encode Panton-Valentine leukocidin (PVL).
Extraction of chromosomal DNA and Polymerase chain reaction (PCR)
Qiagen DNA Purification kit was used to extract DNA from S. aureus isolates according to the manufacturer's instructions (Qiagen). Existence of the mecA gene was investigated in all MRSA isolates were examined. PCR was used to confirm the presence of the mecA gene as described by Murakami et al. 17 Two previously described primers MR1 (5'GTGGAATTGGCCAATACAGG3') and MR2 (5'TAGGTTCTGCAGTACCGGAT3'), 18 were utilised μM of each dNTP (Deoxyribonucleotide mix, 10 mM each), 0.5 µl dNTP, and 2.5 µl 10x PCR buffer. 1.5% agarose gel electrophoresis (80 V in 1× TAE buffer) was used to analyse the PCR products. The gel was stained with 10 μg ml-1 ethidium bromide (Sigma) and visualized using an ultraviolet trans-illuminator to detect the DNA. DNA ladder 100bp (Gibco, Paisley, UK) was run alongside the samples to enable analysis of DNA fragment size in the samples.
RESULTS
S. aureus was detected in 90 (18.4%) of 489 students carried S. aureus. Only 10 (2.04%) students were found to be MRSA carrier. All MRSA isolates were sensitive to vancomycin.
Genetic resistance to methicillin was verified by PCR for detection of the mecA gene. PCR data obtained showed that all isolates of MRSA typed positive for mecA gene. Only one isolate of MRSA carried the PLV gene.
DISCUSSION
S. aureus is a common inhabitant of the upper respiratory tract and responsible for common infections. 20 S. aureus from the nose was shown to be associated with community and hospital associated infections. 4 In healthy population, the nasal carriage rate S. aureus is 10% to 35% and this rate can be influenced by age, underlying illness, and the environment in which the person lives. 21 In our study, student nasal carriage rate of S. aureus was shown to be 18.4%. This result is comparable to previous studies from different countries such as Taiwan. 22 However, the carriage rate in our study was shown to be lower than what has been found in other community-based nasal carriage studies. 23 For example in northern Pakistan, the nasal colonisation of S. aureus was documented in 86 out of 360 students (24%). 7 In the United States from 2003-2004, the S. aureus carriage rate in the civilian non-institutionalized population according to the National Health and Nutrition Examination Survey was 28.6%. 24 In India, the nasal carriage rate of S. aureus was 13% 25 while it was only 12.6% in Sudan. 10 In this study, we found that the nasal carriage of MRSA among the S. aureus isolates was 11.1% and the overall rate of MRSA among the students was 2.04%. In agreement with our results, S. aureus was isolated from nasal swabs of 102 (40.8%) of the 250 volunteers, 2.4% of them were CA-MRSA carriers in Brazil. 26 In Palestine in 2011, the nasal carriage of MRSA among the students was 2.5%. 7 In 2010, a total of 322 University students in Taiwan were screened and 2.2%, of them harboured MRSA. 22 In Pakistan, from 2007 to 2008, MRSA from nasal swabs from anterior nares was 1.5%. 27 In 2001-2002, national MRSA colonization prevalence in USA was 0.8%. 8 On the other hand, the nasal colonisation of MRSA was lower than what was found in other studies. For example, in a study conducted in India in 2009, the anterior nares colonisation of MRSA was 15.4%. 25 In addition, MRSA in different studies for different regions of Iran varied from 20.48% to 90%. 28 A total of 40 (33.3%) S. aureus strains were isolated from the nasal swabs screened in Nigeria, the overall MRSA was 27.5%. 4 Vancomycin is considered one of the last options of antibiotic for cure of S. aureus infections that are resistant to other antibiotics. However, with the antibiotic pressure applied by the mounting utilisation of vancomycin in the management of MRSA infections, resistant strains to vancomycin, known as vancomycin-resistant S. aureus (VRSA), have been reported. Fortunately, no vancomycinresistant strain was found among S. aureus isolates in this report. Interestingly, the sensitivity to vancomycin has been found in virtually all isolates of S. aureus in many studies worldwide. 7, 10 Thus vancomycin could be a wise choice for the management of CA-MRSA.
PVL is the most well-known virulence factor of CA-MRSA. The severest S. aureus-related symptoms and diseases are attributed to the presence of the PVL toxin such as furunculosis, severe necrotising pneumonia, necrotic lesions of the skin and soft tissues and it is also can destroy the cell membrane of white blood cells. 29 PVL is thought to be associ- ated partially to high virulent MRSA strains in the community. 30 There is now considerable molecular evidence indicates that the CA-MRSA strains have developed in the community by the horizontal acquirement of SCCmec elements and PVL genes. 31 The PVL positivity among our CA-MRSA was 10% (only in 1 out of 10 MRSA isolates). Although PVL can consistently found among CA-MRSA strains 32 it has been reported that it is less often found in CA-MRSA strains linked to asymptomatic nasal colonization. 33 Previous studies have revealed that approximately 8-75% of the MRSA nasal isolates carry the PVL gene. 7, 8 Additionally, the percentage of PVL gene was 70-100% among skin isolated MRSA. 32 To conclude, nasal carriage of S. aureus and MRSA is comparable with reports from elsewhere. Actions should be taken to keep the emergence and transmission of these strains to a minimum. Fortunately, all isolates were sensitive to vancomycin. Further research is needed to examine the SCCmec elements and the evolution of MRSA over the time.
